StratDeckMRK

Merck & Co., Inc.

MRK✓
Share

Healthcare · Drug Manufacturers - General · United States

Merck & Co., Inc. operates as a healthcare company worldwide.

Price144.85USD
1D+0.64%
Market cap357B
AnalystsBuy26
Next earnings29 Oct
Loading chart…

Trade ideas

MRK isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusBuy26
Mean score1.75
Mean target152.96+5.60%
Target range105.00–186.00

Value vs sector peers

#19 of 26 in HealthcareWeakest in sector33
  • Fwd P/E15.256
  • P/B8.518
  • Yield2.4%39
  • P/E115.90
  • Rev growth+5.1%20

Nearest in Healthcare

  1. #17SYKStryker CorporationPaying up for quality41
  2. #18GILDGilead Sciences, Inc.Paying up for quality38
  3. #19MRKMerck & Co., Inc.Weakest in sector33
  4. #20DHRDanaher CorporationWeakest in sector32

Fundamentals

P/E115.9
Forward P/E15.2
Price / book8.53
Dividend yield2.36%
Beta0.23
52-week range77.58–156.9285/100
ADV (USD)1.65B
Relative volume0.8
10d avg volume8.42M
Revenue growth+5.10%
EPS growth—

Performance

1D+0.64%
7D-3.65%
1M+6.63%
3M+26.07%
6M+26.39%
YTD+39.63%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named MRK.

Catalysts

Next earnings: 29 Oct

Trade idea history

No trade idea has fired on MRK since the ledger opened.

Get it by email

The board MRK sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.